1[1]Mukharji J, Rude RE, Poole WR, et al. Risk factors for sudden death after acute myocardial infarction: two-year followup[J]. AmJCardiol, 1984,54:31-36.
2[2]Cardiac Arrhythmia Suppression Trial(CAST)Investigators. Porelininary report:effect of encainide and flecainide on mor tality in a randomized trial of arrhythmia suppression after myocardial infarction [J], N Engl J med, 1989,321: 406- 412.
3[3]Cardiac Arrhythmia Suppression Ⅱ Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocar dial infarction[J]. N Engl J Med 1992,327: 227-233.
4[4]Lazzara R. Foom first calss to third class:Recent upheaval in antiarrhythmic therapy-lessons from clinical trials[J]. Am J Cardiol, 1996,78(Suppl 4A) :28.
5[5]Podrid PJ. Amiodarone: Reevaluation of an old drug[J].Ann Intern Med, 1995,122:689.
6[6]Nademanee K, Singh BN, Stevenson WG, et al. Amiodarone in post-MI patient[J]. Circulation, 1993,88(2):764-774.
7[7]Hockings BE, George T, Mahrous F, et al, Effectiveness of amiodarone on ventricular arrhythmias :during and after acute myocardial infarction [J ]. Am J Cardiol, 1987,60 (13): 967-970.
8[8]Burkart F, Pfisterer M, Kiowski W, et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias:Basel Antiarrhythmic Study of Infarct Survival (BASIS)[J].J Am Coil Cardiol, 1990,16(7):1711-1718.
9[9]Pfisterer ME, Kiowski W, Brunner H, et al. Long-term be nefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction[J]. Circulation, 1993,87(2) :309-311.
10[10]Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, et al. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study[J]. J Am Coll Cardiol, 1992,20:1056-1062.
